BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25837263)

  • 1. Periodontal bone loss and risk of epithelial ovarian cancer.
    Babic A; Poole EM; Terry KL; Cramer DW; Teles RP; Tworoger SS
    Cancer Causes Control; 2015 Jun; 26(6):941-7. PubMed ID: 25837263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
    Rice MS; Rist PM; Winter AC; Kurth T; Tworoger SS
    Int J Cancer; 2018 Feb; 142(3):534-539. PubMed ID: 28929486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
    Rice MS; Hankinson SE; Tworoger SS
    Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status.
    Huang T; Eliassen AH; Hankinson SE; Okereke OI; Kubzansky LD; Wang M; Poole EM; Chavarro JE; Tworoger SS
    Int J Cancer; 2016 Feb; 138(4):843-52. PubMed ID: 26335147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort.
    Gapstur SM; Patel AV; Diver WR; Hildebrand JS; Gaudet MM; Jacobs EJ; Campbell PT
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2000-5. PubMed ID: 22941335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
    Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
    Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
    Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):104-109. PubMed ID: 27672055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for epithelial ovarian cancer by histologic subtype.
    Gates MA; Rosner BA; Hecht JL; Tworoger SS
    Am J Epidemiol; 2010 Jan; 171(1):45-53. PubMed ID: 19910378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
    Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
    Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
    Gram IT; Lukanova A; Brill I; Braaten T; Lund E; Lundin E; Overvad K; Tjønneland A; Clavel-Chapelon F; Chabbert-Buffet N; Bamia C; Trichopoulou A; Zylis D; Masala G; Berrino F; Galasso R; Tumino R; Sacerdote C; Gavrilyuk O; Kristiansen S; Rodríguez L; Bonet C; Huerta JM; Barricarte A; Sánchez MJ; Dorronsoro M; Jirström K; Almquist M; Idahl A; Bueno-de-Mesquita HB; Braem M; Onland-Moret C; Tsilidis KK; Allen NE; Fedirko V; Riboli E; Kaaks R
    Int J Cancer; 2012 May; 130(9):2204-10. PubMed ID: 21678398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort.
    Weiderpass E; Sandin S; Inoue M; Shimazu T; Iwasaki M; Sasazuki S; Sawada N; Yamaji T; Tsugane S
    Int J Oncol; 2012 Jan; 40(1):21-30. PubMed ID: 21904774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
    Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
    Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective cohort study of dietary indices and incidence of epithelial ovarian cancer.
    Xie J; Poole EM; Terry KL; Fung TT; Rosner BA; Willett WC; Tworoger SS
    J Ovarian Res; 2014 Dec; 7():112. PubMed ID: 25477244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
    Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
    Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.
    McGuire V; Hartge P; Liao LM; Sinha R; Bernstein L; Canchola AJ; Anderson GL; Stefanick ML; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1059-63. PubMed ID: 27197274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodontal disease severity and cancer risk in postmenopausal women: the Buffalo OsteoPerio Study.
    Mai X; LaMonte MJ; Hovey KM; Freudenheim JL; Andrews CA; Genco RJ; Wactawski-Wende J
    Cancer Causes Control; 2016 Feb; 27(2):217-28. PubMed ID: 26661782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coffee, tea, and caffeine consumption and risk of epithelial ovarian cancer and borderline ovarian tumors: Results from a Danish case-control study.
    Gosvig CF; Kjaer SK; Blaakær J; Høgdall E; Høgdall C; Jensen A
    Acta Oncol; 2015; 54(8):1144-51. PubMed ID: 25629440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
    Rasmussen CB; Kjaer SK; Albieri V; Bandera EV; Doherty JA; Høgdall E; Webb PM; Jordan SJ; Rossing MA; Wicklund KG; Goodman MT; Modugno F; Moysich KB; Ness RB; Edwards RP; Schildkraut JM; Berchuck A; Olson SH; Kiemeney LA; Massuger LF; Narod SA; Phelan CM; Anton-Culver H; Ziogas A; Wu AH; Pearce CL; Risch HA; Jensen A;
    Am J Epidemiol; 2017 Jan; 185(1):8-20. PubMed ID: 27941069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
    Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
    Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.